Top Page
Dai-ichi Life Holdings
(8750)
Dai-ichi Life Holdings (8750) vs. iShares MSCI Japan ETF (EWJ)
Dai-ichi Life Holdings Business Overview & Revenue Model
Dai-ichi Life Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.22T | 9.30T | 9.56T | 7.71T | 7.10T | 6.80T |
| Gross Profit | 9.22T | 9.30T | 10.05T | 9.22T | 7.70T | 7.19T |
| EBITDA | 502.82B | 611.62B | 565.73B | 395.02B | 591.04B | 589.33B |
| Net Income | 337.54B | 429.61B | 320.76B | 173.74B | 409.35B | 363.78B |
Balance Sheet | ||||||
| Total Assets | 68.59T | 69.59T | 67.54T | 61.58T | 65.88T | 63.59T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.89T | 2.06T | 1.62T | 2.18T | 1.88T |
| Total Debt | 1.14T | 1.19T | 975.29B | 949.67B | 870.38B | 899.77B |
| Total Liabilities | 65.01T | 66.12T | 63.66T | 58.71T | 61.47T | 58.79T |
| Stockholders Equity | 3.58T | 3.47T | 3.88T | 2.66T | 4.41T | 4.81T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 532.46B | 946.24B | -250.35B | -561.54B | -118.07B |
| Operating Cash Flow | 0.00 | 592.58B | 997.38B | -132.49B | -462.08B | -79.90B |
| Investing Cash Flow | 0.00 | -968.03B | -644.92B | 117.10B | 940.87B | 615.10B |
| Financing Cash Flow | 0.00 | -73.57B | -145.76B | -325.45B | -180.71B | 65.59B |
Dai-ichi Life Holdings Technical Analysis
Dai-ichi Life Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $4.19T | 18.12 | ― | 3.25% | 11.37% | 27.90% | |
70 Outperform | ¥1.45T | 11.20 | ― | 2.77% | -6.70% | 58.89% | |
69 Neutral | $5.31T | 7.06 | 16.93% | 2.96% | 8.40% | 58.45% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $5.94T | 14.17 | 4.73% | 3.35% | -14.57% | 16.03% | |
62 Neutral | $4.00T | 11.84 | 9.18% | 3.89% | -10.49% | -9.62% | |
61 Neutral | ¥1.76T | 13.71 | 9.22% | 2.96% | -2.35% | 17.94% |
Dai-ichi Life Holdings Corporate Events
Dai-ichi Life Holdings announced the repurchase of 5,618,400 shares of its common stock for approximately 6.9 billion yen, conducted through open-market transactions in September 2025. This move is part of a broader share buyback program authorized by the board, which allows for the repurchase of up to 200 million shares, highlighting the company’s strategy to enhance shareholder value and optimize capital allocation.
The most recent analyst rating on (JP:8750) stock is a Buy with a Yen1380.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings announced the repurchase of 9,040,700 shares of its common stock at an aggregate purchase price of 11,138,624,100 yen during August 2025. This move is part of a broader strategy approved by the board of directors to repurchase up to 200 million shares, aiming to enhance shareholder value and optimize the capital structure.
The most recent analyst rating on (JP:8750) stock is a Buy with a Yen1380.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings has announced a trade name change for its Australian subsidiary from TAL Dai-ichi Life Australia Pty Ltd to TAL Daiichi Life Australia Pty Ltd. This change aligns with the company’s broader strategy to rebrand as Daiichi Life Group, Inc., effective April 2026, and reflects a cohesive identity across its global operations.
The most recent analyst rating on (JP:8750) stock is a Buy with a Yen1380.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings, Inc., a prominent player in the insurance sector, primarily focuses on life insurance services, offering a range of financial products and services to its customers. The company operates globally, with a significant presence in both domestic and international markets.
The Neo First Life Insurance Company, a subsidiary of Dai-ichi Life Holdings, announced its financial results for the three months ending June 30, 2025. The release includes detailed financial summaries, investment results, and balance sheets, indicating the company’s operational performance and financial health during this period.
The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1200.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
The Dai-ichi Frontier Life Insurance Co., Ltd., a subsidiary of Dai-ichi Life Holdings, has announced its financial results for the three months ending June 30, 2025. The release includes detailed financial performance metrics, highlighting the company’s operational and investment outcomes for the period, which are crucial for stakeholders to assess the company’s financial health and strategic positioning.
The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1200.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings announced its financial results for the three months ending June 30, 2025, highlighting key business and investment outcomes. The release provides insights into the company’s financial health, including its balance sheet, earnings, and solvency margin ratio, which are crucial for stakeholders to assess the company’s operational efficiency and market positioning.
The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1200.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings reported a decrease in sales results for the three months ended June 30, 2025, with a notable decline in annualized net premiums of new policies across its group companies. The company’s total assets and adjusted net assets also saw a reduction compared to the previous quarter, reflecting challenges in maintaining growth. Despite these setbacks, the group overseas insurance companies experienced a slight increase in fundamental profit, indicating potential areas of resilience within the company’s operations.
The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1200.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings reported a notable decline in its financial performance for the three months ended June 30, 2025, with ordinary revenues and net income decreasing significantly compared to the same period last year. The company’s comprehensive income also saw a substantial drop, reflecting challenging market conditions. Despite the downturn, the company maintained its financial stability with a slight increase in the ratio of net assets attributable to shareholders. The announcement highlights the company’s strategic adjustments, including a share split, and provides forecasts for the fiscal year ending March 31, 2026, which anticipate further declines in revenues and profits.
The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1200.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.
Dai-ichi Life Holdings announced the repurchase of 12,167,700 shares of its common stock, amounting to over 13.5 billion yen, conducted through open-market repurchase by discretionary trading from July 1 to July 31, 2025. This move is part of a broader strategy approved by the board to repurchase up to 200 million shares, or 5.40% of its total outstanding shares, by May 2026, which could potentially enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1200.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.